Transaction · 0001817199-26-000006

Ring Christine

Ring Christine, CLO, reported an open-market or private sale at Nurix Therapeutics, Inc. involving 14261.000000 shares for an estimated $237618.21. Reported holdings after the transaction were 42749.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCLO
NRIXNurix Therapeutics, Inc.
Filing timeFeb 10
Trade dateFeb 09, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$16.45
Pre-filing
1mo ago +17.3%1w ago +3.9%1d ago +2.4%
Returns since
7d -4.9%30d -5.1%90d -1.0%180d +55.2%1y +65.5%

NRIX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NRIX since 2026-02-10Filed 205 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001817199-26-000006
Common Stock
Transaction date
Feb 09, 2026
Filed Feb 10, 2026, 12:47 AM · 1d delay
Shares
14.2k sh
$1.66k per share
Estimated value
-$23.7M
Computed from shares × price
Holdings after
42.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Reduction Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

  2. F2

    Represents the weighted average sale price. The lowest price at which shares were sold was $16.37 and the highest price at which shares were sold was $16.88. The Reporting Person undertakes to provide…

Original filing · 0001817199-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NRIX